Radiopharm IPO Financial Tombstone

Crystal financial tombstone recognizing the initial public offering (IPO) on the Australian Securities Exchange (ASX) of Radiopharm Theranostics. The Sydney-based biotech specializes in radiopharmaceutical drugs for the treatment of cancer. (21ALJ553)